Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Phase 1 Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers
Study Director
Start Date
9 / 2012
Trial Phase
Trial Status
in data analysis
Current Enrollment
74
Target Enrollment
75
Overview
Compound Associations
Mycobacterial Gyrase Inhibitors